Finland· FI-REL-REL1186

Rinexin

A phenylpropanolamine product containing phenylpropanolamine hydrochloride, registered in Finland by Viatris Oy. The same ATC class is registered in 3 of our 19 countries.

ATC R01BA01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedRinexinATCR01BA01REGISTER NO.FI-REL-REL1186PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Phenylpropanolamine is registered in 3 of 19 countries.

Countries holding a registration under ATC R01BA01 (phenylpropanolamine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 2 of them publish a price we can compare per daily dose

Phenylpropanolamine · ATC R01BA01

3 / 19 countries

  • Finlandprice
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Phenylpropanolamine hydrochloride
Manufacturer
Viatris Oy
Country
Finland (FI)
ATC code
R01BA01
ATC class
Phenylpropanolamine
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Phenylpropanolamine in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phenylpropanolamine products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Norway · Rinexin
  • Sweden · Rinexin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6c0a406b-d60a-42d4-bf2d-fd4738523f1c
GET /v1/drugs/6c0a406b-d60a-42d4-bf2d-fd4738523f1c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.1",
  "form": "depottabletti",
  "route": "Suun kautta",
  "ddd_unit": "g",
  "strength": "50 mg",
  "atc_label": "fenyylipropanoliamiini",
  "ma_number": "7517",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL1186",
  "authorised_at": "1977-12-14"
}

See everything about phenylpropanolamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.